1717 K Street NW, Suite 900

Washington, DC 20006-5349

(877) 363-6376

HELPLINE

NEWS

MesoTV | Meet Shannon Sinclair, RN, BSN, OCN, the on-staff mesothelioma expert at the Foundation

The Meso Foundation Executive Director Julie Powers Iinterviews Patients Services Director Shannon Sinclair

The Meso Foundation’s Executive Director Julie Powers came up with 10 questions to ask during her interview with our Patient Services Director Shannon Sinclair, RN, BSN, OCN. Sinclair is the first point of contact for most of the patients and caregivers who reach out to the Foundation.

Below is an excerpt from their MesoTV interview:

Julie Powers: If someone needs a second opinion, how can you help them navigate that process?


Shannon Sinclair: The great thing about being with the Foundation is that the doctors and all the meso experts around the United States are very familiar with us. I’ve been able to make some great relationships with some of the different places and with some of the different doctors themselves. Generally, I can just email them; I can give them a call and let them know I’ve got a new patient and that I love for them to be able to see them, and they will get their team working on it. So, it’s kind of going sort of the back door of it; it gets the ball rolling a lot faster than if you are trying to do it on your own.

Watch this MesoTV interview to learn more about our Patient Services Director Shannon Sinclair. You can always call or email her at [email protected] or by phone at (703) 879-3821.

Our Sponsors

MesoTV is a program by the Mesothelioma Applied Research Foundation. This program is made possible by our generous sponsors: Belluck & Fox; Maune Raichle Hartley French & Mudd, LLC (MRHFM); Bristol Myers Squibb; AstraZeneca, & TCR2.

Search our previous episodes for topics/speakers of interest to you at www.curemeso.org/mesotv.

Also...

In Other News

Pleural Surgery

Surgery is vital option for treatment for many patients with pleural mesothelioma. This session discusses how pleural surgery works and why it is an option

Read More »

Share:

Facebook
Twitter
LinkedIn